Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...

Please provide your email address to receive an email when new articles are posted on . A small cohort of adults with prediabetes responded favorably toward wearing ...

The Freestyle Libre 14 day is now the longest-lasting self-applied continuous glucose sensing technology available and allows the used to wear the sensor for up to 14 days with high accuracy. ABBOTT ...

Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using these devices to track blood sugar levels for overall health and wellbeing.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In a recent study ...

The announcement comes just after Dexcom, another diabetes company, released its own consumer-friendly sensor. Here's what to know about glucose monitoring. Jessica was a writer on the Wellness team, ...

Estimates from the International Diabetes Federation indicate that in 2021, the number of adults with diabetes in South and Central America was about 341 million. In Brazil, according to data from the ...

Abbott Diabetes Care has recalled certain glucose monitoring sensors after reports of seven deaths and more than 700 injuries possibly linked to malfunctioning devices that could provide inaccurate ...

The U.S. Food and Drug Administration has issued an alert for “a potentially high-risk issue” regarding two glucose monitor sensors that have been malfunctioning and linked to multiple fatalities. The ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.